"Skin Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the SKIN.
| Descriptor ID |
D012878
|
| MeSH Number(s) |
C04.588.805 C17.800.882
|
| Concept/Terms |
Skin Neoplasms- Skin Neoplasms
- Neoplasms, Skin
- Neoplasm, Skin
- Skin Neoplasm
Cancer of Skin- Cancer of Skin
- Skin Cancers
- Cancer of the Skin
- Skin Cancer
- Cancer, Skin
- Cancers, Skin
|
Below are MeSH descriptors whose meaning is more general than "Skin Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Skin Neoplasms".
This graph shows the total number of publications written about "Skin Neoplasms" by people in this website by year, and whether "Skin Neoplasms" was a major or minor topic of these publications.
View timeline visualization
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 24 | 3 | 27 |
| 1996 | 30 | 5 | 35 |
| 1997 | 40 | 2 | 42 |
| 1998 | 21 | 2 | 23 |
| 1999 | 28 | 3 | 31 |
| 2000 | 43 | 4 | 47 |
| 2001 | 47 | 7 | 54 |
| 2002 | 46 | 10 | 56 |
| 2003 | 61 | 10 | 71 |
| 2004 | 52 | 12 | 64 |
| 2005 | 76 | 18 | 94 |
| 2006 | 65 | 17 | 82 |
| 2007 | 60 | 14 | 74 |
| 2008 | 67 | 12 | 79 |
| 2009 | 76 | 11 | 87 |
| 2010 | 99 | 17 | 116 |
| 2011 | 135 | 11 | 146 |
| 2012 | 137 | 19 | 156 |
| 2013 | 130 | 19 | 149 |
| 2014 | 154 | 30 | 184 |
| 2015 | 152 | 20 | 172 |
| 2016 | 142 | 19 | 161 |
| 2017 | 141 | 13 | 154 |
| 2018 | 148 | 11 | 159 |
| 2019 | 158 | 9 | 167 |
| 2020 | 153 | 17 | 170 |
| 2021 | 154 | 7 | 161 |
| 2022 | 125 | 1 | 126 |
| 2023 | 115 | 3 | 118 |
| 2024 | 70 | 22 | 92 |
| 2025 | 3 | 0 | 3 |
Below are the most recent publications written about "Skin Neoplasms" by people in Profiles.
-
Combined programmed cell death protein 1 and cytotoxic T-lymphocyte associated protein 4 blockade in an international cohort of patients with acral lentiginous melanoma. Br J Dermatol. 2025 Jan 24; 192(2):316-326.
-
T helper 2 cell-directed immunotherapy eliminates precancerous skin lesions. J Clin Invest. 2025 Jan 02; 135(1).
-
Dermatofibrosarcoma Protuberans, Version 1.2025, NCCN Clinical Practice Guidelines In Oncology. J Natl Compr Canc Netw. 2025 01; 23(1).
-
Chondroitin sulfate proteoglycan 4 increases invasion of recessive dystrophic epidermolysis bullosa-associated cutaneous squamous cell carcinoma by modifying transforming growth factor-β signalling. Br J Dermatol. 2024 Dec 23; 192(1):104-117.
-
FDG PET/CT in Cutaneous Involvement of Plasmablastic Plasma Cell Myeloma. Clin Nucl Med. 2025 Feb 01; 50(2):e127-e129.
-
Achieving Adherence With NCCN Guidelines for Nonmelanoma Skin Cancer Regarding Peripheral and Deep En Face Margin Assessment (PDEMA). J Natl Compr Canc Netw. 2024 Nov; 22(9).
-
A retrospective multicenter cohort study of differences in clinical characteristics of Infantile Hemangiomas in preterm and term infants: Prematurity increases risk of permanent cutaneous sequelae. J Am Acad Dermatol. 2025 Mar; 92(3):546-553.
-
Innovations in Actinic Keratosis. Dermatol Clin. 2025 Jan; 43(1):77-94.
-
The Utility of PRAME and Ki-67 as Prognostic Markers for Cutaneous Melanoma. Am J Dermatopathol. 2025 Jan 01; 47(1):9-16.
-
NAPRT Silencing in FH-Deficient Renal Cell Carcinoma Confers Therapeutic Vulnerabilities via NAD+ Depletion. Mol Cancer Res. 2024 10 02; 22(10):973-988.